Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX

Kewalramani Reshma sold 11,866 Vertex Pharmaceuticals Incorporated shares (Form 4)

Traded Nov 6, 2026 · Filed Nov 10, 2026

On Nov 6, 2026, Kewalramani Reshma (Director, CEO & President) sold 11,866 Vertex Pharmaceuticals Incorporated shares at US$531.53 for US$6.31M under a trading plan, leaving 86,471 shares. Filed Nov 10, 2026 (Form 4).

Sold
11,866 shares
Price
US$531.53
Value
US$6.31M
Holding after
86,471 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, CEO & President

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 6, 2026Common StockSale11,866US$531.5386,471Direct

Source

Download original · View original at SEC

Related